SciSight Ecosystem
WoS ESCI Q4Scopus Q3SCImago #13,932CAS 4区Gold OA

Hepatic Oncology

Country: United Kingdom•WoS SCIE Quartile: Q4•Scopus SJR: 0.411•SCImago Rank: #13,932•Identifier (ISSN):2045-0923(Print)/2045-0931(Online)•Articles / Year: 7•Estimated Publication Fee (APC): $2,686 USD
Clarivate JCR Index Advisory: Active (ESCI)
Clarivate IF (2026)Q4
2
↑ +0.7

Leading citation impact metric from Clarivate Journal Citation Reports

JCR Release Date: 2026-06-17
H-Index (Hirsch Index)
5

5 papers with at least that number of citations each

WoS: ESCIQ4
Self-Citation Rate0%
Safe Level (< 15%)Warning Level (> 20%)
Self-citation below 15% indicates strong scholarly independence.
Volume & Open AccessGold OA
7articles/year
100% Gold OA•100% Original Research

State Council for Professorship (HĐGSNN) Scoring

Quyết định số 26/QĐ-HĐGSNN ngày 11/7/2025 (Mục quốc tế)

1.00pts
Latest Max Score
Estimated (Dec 26)
Scoring Basis: WoS Q4(IF: 2)

HĐGSNN Score History

By article publication year
YearMax ScoreEvaluation DetailsSource
20261.00đ
WoS Q4(IF: 2)
🔵 Computed
20251.00đ
WoS Q4(IF: 1.3)
🔵 Computed
20241.00đ
WoS Q4(IF: 1.2)
🔵 Computed
20231.00đ
WoS Q4(IF: 5)
🔵 Computed

Note: Domestic journal scores are officially collected from annual HĐGSNN decisions across councils. International journal scores are dynamically computed according to Decision 26/QĐ-HĐGSNN based on quartile and citation metrics in the publication year.

Aims & Scope

Primary liver cancer is the sixth most common cancer in the world, and the third most common cause of death from malignant disease. Traditionally more common in developing countries, hepatocellular carcinoma is becoming increasingly prevalent in the Western world, primarily due to an increase in hepatitis C virus infection. Emerging risk factors, such as non-alcoholic fatty liver disease and obesity are also of concern for the future. In addition, metastatic tumors of the liver are more common than primary disease. Some studies report hepatic metastases in as many as 40 to 50% of adult patients with extrahepatic primary tumors. Hepatic Oncology publishes original research studies and reviews addressing preventive, diagnostic and therapeutic approaches to all types of cancer of the liver, in both the adult and pediatric populations. The journal also highlights significant advances in basic and translational research, and places them in context for future therapy. Hepatic Oncology provides a forum to report and debate all aspects of cancer of the liver and bile ducts. The journal publishes original research studies, full reviews and commentaries, with all articles subject to independent review by a minimum of three independent experts. Unsolicited article proposals are welcomed and authors are required to comply fully with the journal's Disclosure & Conflict of Interest Policy as well as major publishing guidelines, including ICMJE and GPP3.

Topics Covered (Recognized by AI)
Medicine99.5%Internal medicine92.5%Biology86%Genetics83.9%Cancer research66.1%Hepatocellular carcinoma64%Pathology56.5%Oncology54.8%Cancer47.3%Surgery47.3%Gastroenterology37.6%Chemistry32.8%Biochemistry27.4%Radiology24.7%
Primary Research Areas

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #13,932Scopus Q3SCImago Profile
Scopus Coverage:2016, 2020, 2022-2025
Scopus Broad Areas:Medicine
Scopus Citation Rank (SJR)Q3
0.411

Weighted prestige citation metric per document indexed in the Scopus database.

Tứ phân vị: Scopus Q3
Scopus H-Index (2025)
5

Measures cumulative publication volume and citation impact.

Scopus Database Indexed (2025)
Citations / Doc (2 years)
1.78

Average citations received per document published in the 2-year window.

2-Year Citation Window
Estimated Publication Fee (APC)
$2,686 USD

Estimated Article Processing Charge for Open Access publication.

Chi phí ước tính / bài báo

Scopus 3-Year Publication & Citation Window

3-Year Citations20
3-Year Documents11
Citable Documents11

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate51.4%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

HepatologyQ3
OncologyQ3

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):
4区 (Zone 4)Medicine
Minor Category (Specific Field):
4区ONCOLOGY
CAS Early Warning List History:
Updated annually: 2020 – 2024
2020
Not warned
2021
Not warned
2022
Not warned
2023
Not warned
2024
Not warned

Publishing & Editorial Information

Detailed publisher, peer-review turnaround, and publication cycle specifications

Publisher Review Speed
Updating
Average time to first editorial decision
Online Publication Speed
Updating
Time from acceptance to online publication
Official Acceptance Rate
Updating
Manuscript acceptance rate confirmed by the publisher
Open Access Model
Gold OA
OA publishing option or traditional subscription
Publisher
Future Medicine Ltd
Publication Language
English
Frequency
Periodic
Indexing & Databases
ESCIDOAJPubMed

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI
CategoryIndexRankQuartile
ONCOLOGY
JCRESCI
250/333Q4
ONCOLOGY
JCIESCI
283/333Q4

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year
YearImpact FactorArticles / YearTotal Citations
2026—20
20251.3826
20241.2410
20235430
2022—411
2021—891
2020—21534
2019—463
2018—11327
2017—17234
2016—17245
2015—58745
Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Impact Factor Trend (2018–2024)

Clarivate IF trend for Hepatic Oncology

WoS Q4
02462023202420251.30
Annual Impact Factor Metric
2025:1.3

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth
Self-citation: 0%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Similar Journals in Discipline

Journals in the same research field with comparable impact metrics

Record UUID: 69da93aa-6996-4436-9215-50ff79441375
Database Updated: 2026-10-01